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Organotins belong to the most widely used
organometallic compounds, with an esti-
mated annual production of approximately
50,000 tons. Derivatives of dialkyltin
compounds such as dibutyltin (DBT),
diphenyltin (DPT), and dioctyltin (DOT)
are used in industry as stabilizers in polyvinyl
chloride (PVC) and as catalysts in various
products, whereas trialkyltins, including
tributyltin (TBT) and triphenyltin (TPT) are
used in agriculture as fungicides and pesti-
cides and as antifouling agents for large ships
(Fent 1996). Organotins are ubiquitous envi-
ronmental pollutants especially relevant for
water ecosystems. Accumulation of these
lipophilic compounds has been observed in
various species of snails, mussels, and fish
(Bhosle et al. 2004; Coelho et al. 2002), caus-
ing an increased incidence of sterility or
imposex (imposition of male sex characters
onto the female) (Evans and Nicholson 2000;
Fent 2003).
The main sources of organotin intake for
humans are seafood contaminated because of
the exposure to antifouling agents (Takahashi
et al. 1999), and drinking water contami-
nated because of the leaching from PVC
water pipes (Sadiki and Williams 1999).
Additional sources are indoor dust, and liq-
uids stored in plastic containers, including
various alcoholic beverages (Liu and Jiang
2002). In higher species, including mammals,
organotins tend to accumulate in certain
organs, namely liver, kidney, and brain (Fait
et al. 1994). Organotins efﬁciently penetrate
through the skin and easily cross the placenta
and blood–brain barrier (Adeeko et al. 2003;
Cooke et al. 2004; Hasan et al. 1984).
Comparison of the effects of various tri-
alkyltins indicated that the compounds with
short alkyl groups such as trimethyltin (TMT)
and triethyltin were mainly neurotoxic, whereas
organotins with alkyl chains of intermediate
length (tripropyltin and TBT) were primarily
immunotoxic (Snoeij et al. 1985). The higher
trialkyltin homologs trihexyltin and trioctyltin
were found to be only slightly toxic; however,
further metabolism in vivo converted them to
their dialkyltin forms, which are also highly
immunotoxic (Penninks et al. 1985; Seinen
and Willems 1976; Snoeij et al. 1988). A single
oral dose of DOT, DBT, or TBT induces a
dose-related reduction of the relative thymus
weight in rats, and impaired cell-mediated
immunity was observed after dietary exposure
to TPT for several weeks (Krajnc et al. 1984;
Seinen et al. 1977a, 1977b; Snoeij et al. 1988;
Vos et al. 1984a, 1984b, 1990). Furthermore,
exposure of pregnant rats to organotins causes
reduced birth weight (Adeeko et al. 2003;
Cooke et al. 2004; Crofton et al. 1989).
Reduced birth weight has also been
observed with prolonged intrauterine gluco-
corticoid exposure (Benediktsson et al. 1993;
Lindsay et al. 1996a, 1996b; Stewart et al.
1995). After such an insult, circulating cortisol
levels remained elevated throughout adult life,
indicating a permanently disturbed regulation
of the hypothalamic–pituitary–adrenal axis,
which leads to a higher susceptibility for
cardiovascular and metabolic disorders includ-
ing obesity, insulin resistance, and type II dia-
betes (Drake et al. 2005; Seckl et al. 2000). In
the placenta the fetus is protected from the
high maternal glucocorticoid concentration
through the activity of 11β-hydroxysteroid
dehydrogenase type 2 (11β-HSD2), which
converts active 11β-hydroxyglucocorticoids
(cortisol in human, corticosterone in rodents)
into inactive 11-ketoglucocorticoids (cortisone
in human, 11-dehydrocorticosterone in
rodents) (reviewed in Stewart and Krozowski
1999). Impaired 11β-HSD2 activity, due to
mutations or the presence of inhibitors such as
glycyrrhetinic acid (GA), strongly correlates
with reduced birth weight and metabolic com-
plications in later life of the offspring (Drake
et al. 2005; Lindsay et al. 1996b; Odermatt
2004; Seckl et al. 2000).
Moreover, exposure of rats to excessive
levels of glucocorticoids causes thymus involu-
tion (Schuurman et al. 1992), a phenomenon
also evident after exposure to organotins.
Treatment of rats with high doses of the
11β-HSD inhibitor GA led to a significant
elevation of systemic glucocorticoid levels
accompanied by thymocyte apoptosis
(Horigome et al. 1999).
Despite the fact that both exposure to
excessive levels of organotins and glucocorti-
coids cause low birth weight and thymus
involution in animal models, the impact of
organotins on the control of the intracellular
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Organotins, important environmental pollutants widely used in agricultural and industrial applica-
tions, accumulate in the food chain and induce imposex in several marine species as well as neuro-
toxic and immunotoxic effects in higher animals. Reduced birth weight and thymus involution,
observed upon exposure to organotins, can also be caused by excessive glucocorticoid levels. We
now demonstrate that organotins efficiently inhibit 11β-hydroxysteroid dehydrogenase type 2
(11β-HSD2), converting active 11β-hydroxyglucocorticoids into inactive 11-ketoglucocorticoids,
but not 11β-HSD1, which catalyzes the reverse reaction. Di- and tributyltin as well as di- and
triphenyltin inhibited recombinant and endogenous 11β-HSD2 in lysates and intact cells with IC50
values between 500 nM and 3 µM. Dithiothreitol protected 11β-HSD2 from organotin-dependent
inhibition, indicating that organotins act by binding to one or more cysteines. Mutational analysis
and 3-D structural modeling revealed several important interactions of cysteines in 11β-HSD2.
Cys90, Cys228, and Cys264 were essential for enzymatic stability and catalytic activity, suggesting
that disruption of such interactions by organotins leads to inhibition of 11β-HSD2. Enhanced glu-
cocorticoid concentrations due to disruption of 11β-HSD2 function may contribute to the
observed organotin-dependent toxicity in some glucocorticoid-sensitive tissues such as thymus and
placenta. Key words: cortisol, dibutyltin, 11β-hydroxysteroid dehydrogenase, glucocorticoid, inhibi-
tion, organotin, toxicity, tributyltin, triphenyltin. Environ Health Perspect 113:1600–1606 (2005).
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studied. Therefore, we investigated the effect
of various organotins on the activities of
11β-HSD1, converting inactive 11-keto-
glucocorticoids to active 11β-hydroxygluco-
corticoids, and of 11β-HSD2, catalyzing the
opposite reaction. We also studied the mecha-
nism of organotin-dependent inhibition of
11β-HSD2.
Materials and Methods
Chemicals and reagents. We purchased
[1,2,6,7-3H]-cortisol, [2,4,6,7-3H]-estrone,
and [2,4,6,7-3H]-estradiol from Amersham
Pharmacia (Piscataway, NJ, USA); [1,2,6,7-
3H]-cortisone from American Radiolabeled
Chemicals (St. Louis, MO, USA); cell culture
media and supplements from Invitrogen
(Carlsbad, CA, USA); and steroid hormones
from Steraloids (Wilton, NH, USA). All other
chemicals were obtained from Fluka AG
(Buchs, Switzerland) and were of the highest
grade available. Organotins were dissolved in
dimethyl sulfoxide (DMSO) and stored as
20-mM stock solutions at –70°C. Human
11β-HSD1 and 11β-HSD2 expression con-
structs in pcDNA3 vector (Invitrogen) were
described previously (Odermatt et al. 1999).
Plasmids containing cDNA from human
17β-HSD1 or 17β-HSD2, kindly provided
by Stefan Andersson, were recloned into
pcDNA3 vector by PCR with primers at the
5´ end containing a HindIII restriction site
(17β-HSD1) or a BamHI restriction site
(17β-HSD2), a Kozak consensus sequence
(Kozak 1989) and the initiation codon, and
primers at the 3´ end containing a stop codon
followed by an XbaI restriction site. All con-
structs were veriﬁed by sequencing.
Cell culture. HEK-293 (human embryonic
kidney) cells stably transfected with FLAG
(Asp–Tyr–Lys–Asp–Asp–Asp–Asp–Lys)-tagged
human 11β-HSD2 (Schweizer et al. 2003)
were grown at 37°C under 5% carbon dioxide
to 60–70% conﬂuence in Dulbecco’s modiﬁed
Eagle medium (DMEM) supplemented with
10% fetal calf serum, 4.5 g/L glucose, 50 U/mL
penicillin/streptomycin, and 2 mM glutamine.
SW-620 (human colorectal adenocarcinoma)
cells and JEG-3 (human choriocarcinoma) cells
were cultured according to the recommenda-
tions of the supplier (American Type Culture
Collection, Manassas, VA, USA). The recently
described RCCD-2 aldosterone-sensitive rat
cortical collecting duct cells (Djelidi et al. 2001)
were cultured in DMEM/Ham’s F-12 (1:1), 14
mM NaHCO3, 2 mM glutamine, 10 U/mL
penicillin/streptomycin, and 20 mM HEPES,
pH 7.4.
Activity assays in cell lysates. To measure
11β-HSD2 activity, stably transfected HEK-
293 cells (Schweizer et al. 2003) were grown in
10-cm culture dishes to 90% conﬂuence. Cells
were rinsed 3 times with phosphate-buffered
saline (PBS) and resuspended in 2 mL ice-cold
buffer TS2 (100 mM NaCl, 1 mM EGTA,
1 mM EDTA, 1 mM MgCl2, 250 mM
sucrose, 20 mM Tris-HCl, pH 7.4). Aliquots
of the cell suspension were frozen at –20°C,
retaining full enzymatic activity for at least
3 months. For determinationof 11β-HSD2
activity, aliquots were thawed, sonicated, and
diluted 1:12 in buffer TS2 (4°C). We carried
out reactions in a ﬁnal volume of 20 µL con-
taining 10 nCi [1,2,6,7-3H]-cortisol, 400-µM
NAD+, and different concentrations of un-
labeled cortisol. Final cortisol concentrations
were 40 nM for measurements of inhibitors
and ranged between 10 nM and 200 nM for
determination of apparent Km values.
Incubations were for 10 min at 37°C.
For determination of 11β-HSD1,
17β-HSD1, and 17β-HSD2 activity,
HEK-293 cells transfected by the calcium-
phosphate precipitation method were har-
vested 48 hr later, washed with PBS, and
centrifuged for 3 min at 150 × g. Supernatants
were removed, cell pellets quick-frozen in a
dry ice ethanol bath, and stored at –70°C. For
assaying 11β-HSD1, we dissolved pellets in
TS2 buffer; for 17β-HSD1 or 17β-HSD2, we
used a buffer containing 50 mM potassium
phosphate, 20% glycerol, and 1 mM EDTA.
We measured 11β-HSD1 oxoreductase activ-
ity as described recently (Atanasov et al.
2004), using radiolabeled cortisone as sub-
strate. 17β-HSD1 and 17β-HSD2 activities
were measured in the presence of radiolabeled
estrone or estradiol and unlabeled steroid at
ﬁnal concentrations of 200 nM and 500 µM
NADPH or NAD+, respectively.
Determination of 11β-HSD2 activity in
intact cells and MTT cytotoxicity assay.
HEK-293 cells stably transfected with
11β-HSD2 (25,000 cells per well) were seeded
24 hr prior to the assay in poly-D-lysine coated
96-well Biocoat plates (Becton Dickinson,
Basel, Switzerland). The medium was carefully
removed, followed by the addition of 30 µL
fresh medium, 10 µL medium containing var-
ious concentrations of organotins, and 10 µL
radiolabeled cortisol. The reaction volume was
50 µL, with a final cortisol concentration of
40 nM. The cells were incubated for 2 hr at
37°C under 5% CO2. We stopped reactions
by adding an excess of unlabeled cortisone and
cortisol in methanol, and separated steroids
using thin-layer chromatography, followed by
scintillation counting. 11β-HSD2 activity in
JEG-3, SW-620, and RCCD-2 cells was
measured similarly by adjusting the cell den-
sity and reaction time to obtain a maximal
conversion of cortisol between 15 and 25%.
To ensure that the observed inhibition of
11β-HSD2 activity was not due to cell death,
we assessed cytotoxicity of organotin com-
pounds parallel to the activity assay under
identical conditions. The corresponding
organotin compound was added to the cells,
followed by incubation for 2 hr at 37°C
under 5% CO2. Cells were washed with PBS
and incubated in fresh medium containing
0.5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT).
After conversion of MTT, we removed the
medium and added 200 µL DMSO to the
insoluble fraction. Conversion of MTT was
kept below OD 0.9 (A570–A690).
Site-directed mutagenesis and analysis of
mutant 11β-HSD2 enzymes. Mutations were
introduced into the C-terminally FLAG-
tagged 11β-HSD2 cDNA in Bluescript vector
by site-directed mutagenesis according to the
Quick Change mutagenesis kit (Stratagene,
Amsterdam, the Netherlands) (Odermatt et al.
1999). All constructs were veriﬁed by sequenc-
ing and recloned into pcDNA3 expression
vector. Wild-type and mutant enzymes were
expressed in HEK-293 cells, lysates were pre-
pared, and proteins were separated by sodium
dodecyl sulfate (SDS) gel electrophoresis.
Proteins were transferred to nitrocellulose, and
expression levels of 11β-HSD2 constructs
were detected using mouse monoclonal anti-
body M2 raised against the FLAG epitope and
visualized with a horseradish peroxidase conju-
gated anti-mouse antibody and enhanced
chemiluminescence Western kit (Pierce,
Rockford, IL, USA). After detection of
11β-HSD2 constructs, nitrocellulose mem-
branes were stripped and incubated with rab-
bit polyclonal anti-actin IgG (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA)
and horseradish peroxidase–conjugated goat
anti-rabbit IgG to adjust for the amount of
proteins loaded on the gel. The expression of
mutant relative to wild-type enzyme was
adjusted for calculation of kinetic parameters.
Three-dimensional modeling. The 3-D
model of human 11β-HSD2 from Arnold
et al. (2003) was used with NAD+ extracted
from protein data bank file 1AHI (Tanaka
et al. 1996). Human 11β-HSD2 was then
minimized for 100,000 iterations with
Discover 3 (Accelrys Inc., San Diego, CA,
USA) using the extensible and systematic
force field (ESFF), with a distant dependent
dielectric constant of 2, to model water in the
protein.
Statistical analysis. Enzyme kinetics were
analyzed by nonlinear regression using Data
Analysis Toolbox (MDL Information Systems
Inc., Nashville, TN, USA) assuming first-
order rate kinetics. Data represent mean ± SD
of at least four independent experiments.
Results
Inhibition of 11β-HSD2 but not 11β-HSD1
by organotins. To investigate whether organ-
otins disrupt the control of the ratio of active
to inactive glucocorticoids by inhibition of
11β-HSD enzymes, we incubated lysates of
Inhibition of 11β-HSD2 by organotins
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11β-HSD constructs with various concentra-
tions of TBT and TPT and determined enzy-
matic activities. TBT and TPT did not
inhibit the 11β-HSD1–dependent conversion
of cortisone to cortisol at concentrations 
up to 200 µM (Table 1). In contrast the
11β-HSD2–dependent conversion of cortisol
to cortisone was efﬁciently inhibited by both
compounds with IC50 (median inhibitory
concentration) values in the low micromolar
range, indicating that organotins selectively
abolish the 11β-HSD2–dependent inactiva-
tion of glucocorticoids.
Despite that 11β-HSD1 and 11β-HSD2
interconvert the same substrate, they are phylo-
genetically relatively distant enzymes, sharing
only 18% identical amino acid sequence
(Baker 2004). 11β-HSD2 is more closely
related to 17β-HSD2, with an amino acid
sequence about 45% identical. Thus, we also
determined the conversion of estrone to the
more potent estrogen estradiol by 17β-HSD1
and the reverse reaction by 17β-HSD2 in the
presence of various concentrations of organ-
otins. As shown in Table 1, neither TBT nor
TPT inhibited 17β-HSD1. 17β-HSD2 activ-
ity was inhibited by TPT at a 6-fold higher
IC50 value compared with that of 11β-HSD2,
indicating that organotins preferentially inhibit
11β-HSD2.
Because trialkyltins are progressively
dealkylated by microorganisms in the environ-
ment and in mammalian organs including
brain, liver, and kidneys (Gadd 2000), and
because the dialkyltins DBT and DPT are
major metabolites with significant toxicity
(Penninks et al. 1985; Seinen and Willems
1976; Snoeij et al. 1988), we included these
two compounds in the study. Analysis of all
four organotin compounds revealed compara-
ble inhibitory properties both in lysates and
intact cells expressing 11β-HSD2 with IC50
values in the low micromolar range (Table 1).
In intact cells the trialkyltins were approxi-
mately 3-fold more potent than the dialkyltins,
and the phenyltins were slightly more potent
than the butyltins, well correlating with the
hydrophobicity of these compounds. It is
important to note that the inhibitory potency
of organotins is comparable with that of
the well-known 11β-HSD inhibitor GA in
intact cells.
Dithiothreitol but not glutathione protects
11β-HSD2 from inhibition by organotins. To
investigate the molecular mechanism of
organotin-induced inhibition of 11β-HSD2,
we measured the effect of organotins in the
presence or absence of the reducing agent
dithiothreitol (DTT) (Figure 1). DTT alone
did not signiﬁcantly alter enzymatic activity.
A concentration of 2 mM DTT, added
simultaneously with 5 µM of the correspond-
ing organotin compound, restored 70–80%
of 11β-HSD2 activity. Upon preincubation
of 11β-HSD2 with organotins for 15 min,
50–60% of the enzymatic activity could be
restored (not shown), indicating that most
but not all of the inhibitory effect was
reversible. In contrast to the dithiol DTT, the
monothiol glutathione was not able to pre-
vent organotin-dependent inhibition of
11β-HSD2 (not shown).
We recently demonstrated that dithiocar-
bamates, another environmentally relevant
class of compounds, inhibit 11β-HSD2.
Cofactor NAD+ partially protected the
enzyme, suggesting that covalent modiﬁcation
of the thiol group at Cys90 in the cofactor-
binding region may be responsible for dithio-
carbamate-induced inactivation of 11β-HSD2
(Atanasov et al. 2003). In contrast we found
no protective effect of NAD+ on organotin-
induced enzyme inhibition (not shown), indi-
cating an inhibitory mechanism distinct from
that of dithiocarbamates.
Functional analysis of the cysteine residues
of 11β-HSD2. We have previously shown that
substitution of Cys90 by serine leads to abol-
ished protein expression and enzymatic activity
(Atanasov et al. 2003). Because NAD+ did not
protect 11β-HSD2 from organotin-induced
inhibition, we analyzed the functional rele-
vance of the remaining eight cysteine residues
by mutating them to serines. All nine cysteine-
to-serine mutants contained a FLAG epitope at
the C-terminus, allowing the quantiﬁcation of
the relative protein expression (Figure 2). Five
of the mutant enzymes showed significantly
reduced expression. No band could be detected
for mutant Cys228Ser and only a very weak
band for Cys90Ser was detected. As expected,
no activity could be measured using lysates
from cells transfected with cDNA for either of
these two mutant enzymes. Significantly
reduced expression was also observed for
mutants Cys128Ser and Cys188Ser. When the
catalytic activity of these mutant enzymes was
adjusted for their reduced expression, an appar-
ent Vmax comparable to that of wild-type
11β-HSD2 was obtained (Table 2), indicating
reduced enzyme stability but intact catalytic
activity. For mutant Cys264Ser, which also
showed reduced expression, a slightly higher
Vmax was obtained. Comparison of the kinetic
parameters revealed altered kinetic parameters
for mutant Cys264Ser, with a 3-fold higher
apparent Km. Mutation of Cys264 to serine also
resulted in a 2-fold increase in the IC50 for
TBT, suggesting a role for Cys264 in the bind-
ing of cortisol and in the interaction with
organotins with 11β-HSD2.
Analysis of the mode of organotin-depen-
dent inhibition of 11β-HSD2. We next inves-
tigated the effect of preincubation of
11β-HSD2 with either 1.5 µM TPT or 2 µM
TBT for 5 or 10 min. Although there was a
slight tendency toward increased inhibitory
effect upon preincubation with TBT, the
changes did not reach signiﬁcance (Figure 3),
in line with reversible inhibition. To further
assess the mode of inhibition, we determined
the change of apparent Km and Vmax in the
Atanasov et al.
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Table 1. Selective inhibition [IC50 (µM)] of 11β-HSD2 by organotins.a
Cell lysate Intact cells
Organotin 17β-HSD1 17β-HSD2 11β-HSD1 11β-HSD2 11β-HSD2
TBT > 200 > 200 > 200 1.90 ± 0.66 1.52 ± 0.43
DBT ND ND ND 1.95 ± 0.27 5.03 ± 0.70
TPT > 200 19 ± 3 > 200 3.19 ± 0.73 0.99 ± 0.24
DPT ND ND ND 1.42 ± 0.17 2.89 ± 0.59
GA ND ND ND 0.40 ± 0.08 1.01 ± 0.29
ND, not determined.
aData are mean ± SD from at least four independent experiments measured in duplicate.
Figure 1. DTT prevents organotin-dependent inhibi-
tion of 11β-HSD2. The oxidation of cortisol by
11β-HSD2 was determined using cell lysates, as
described in “Materials and Methods.” Addition of
DTT at a final concentration of 2 mM restored
70–80% of the activity measured in absence of
organotins.
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Figure 2. Expression of wild-type 11β-HSD2 and
cysteine to serine mutants. C-terminally FLAG-epi-
tope tagged wild-type and mutant 11β-HSD2
enzymes were expressed in HEK-293 cells, and
protein expression was analyzed by Western blot-
ting as described in “Materials and Methods.”
After detection of the FLAG-tagged 11β-HSD2
enzymes, nitrocellulose membranes were stripped,
and actin expression was detected as a control for
the amount of protein loaded on the SDS gel. A
representative blot from three comparable experi-
ments is shown.
Actin
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absence or presence of TBT. The apparent Km
increased 2- and 3-fold upon incubation with
2 µM and 3 µM TBT (62 ± 17 nM for the
control compared with 137 ± 24 nM and
197 ± 33 nM for treated samples, respec-
tively), whereas Vmax decreased slightly (2.14 ±
0.32 nmol × h–1 × mg–1 for the control com-
pared with 1.66 ± 0.40 nmol × h–1 × mg–1
and 1.48 ± 0.48 nmol × h–1 × mg–1 for treated
samples, respectively). These ﬁndings suggest a
mixed-competitive mode of inhibition, with
most of the inhibitory effect being reversible.
To further test this assumption, we meas-
ured the effect of diluting the enzyme–
inhibitor complex (EI) (Figure 4). In case of a
competitive mode of inhibition, dilution of the
EI complex would lead to a decreased inhibitor
concentration and reduced competition with
the substrate, hence reduced enzyme inhibi-
tion. If covalent enzyme modification takes
place, the dilution of the EI complex would
not change the proportion of modified to
unmodiﬁed molecules, meaning that after the
dilution of EI there would be no change of the
relative inhibition compared with the control.
In case of TBT-induced inhibition of
11β-HSD2, a 2-fold and 4-fold dilution of the
EI complex led to a proportional decrease of
the relative inhibitory effect, indicating a tran-
sient interaction of the organotin compound
with 11β-HSD2.
Inhibition of 11β-HSD2 in endogenous
cell lines. Because organisms are exposed to var-
ious sources of organotins and these chemicals
undergo dealkylation in vivo, cells in tissues are
generally exposed to a mixture of organotins.
Therefore, we compared the activity of
11β-HSD2 in intact cells either upon incuba-
tion with DBT, TBT, DPT, or TPT alone, at
concentrations 50% below their IC50 value, or
after incubation with a mixture of the four
chemicals (Figure 5). Whereas each compound
alone reduced 11β-HSD2 activity only slightly,
the mixture showed additive inhibitory effects
and signiﬁcantly inhibited enzymatic activity,
indicating that the distinct organotins act by
the same mechanism. We observed this
phenomenon in transfected HEK-293 cells as
well as in endogenous cell lines.
We next determined the potential of TBT
to inhibit 11β-HSD2 activity in cell lines
derived from tissues with endogenous expres-
sion of this enzyme, for example, placenta,
renal cortical collecting duct, and colon
(Figure 6). In placenta-derived JEG-3 cells and
in colon-derived SW-620 cells, the inhibition
of 11β-HSD2 by TBT was highly similar to
that observed in HEK-293 cells. We observed
approximately 2-fold stronger inhibition in
renal cortical-collecting duct–derived RCCD-2
cells, with an IC50 of 0.83 ± 0.23 µM for TBT.
Discussion
Relatively little is known about the molecular
targets of organotins despite their wide range of
toxic effects and that they can be readily
detected in the blood of humans. In this article
we describe the organotin-dependent inhibi-
tion of 11β-HSD2. Our data suggest that
organotins inhibit 11β-HSD2 by a mostly
reversible, mixed-competitive mode of inhibi-
tion. Comparison of the kinetic parameters
obtained from measurements with lysates and
intact cells expressing 11β-HSD2 indicates
that the trialkyltins enter the cell more easily,
which explains their more potent effects in
intact cells. However, dialkyltins display equal
or even enhanced inhibitory potency in lysates.
Organotin-induced inhibition of 11β-HSD2
was prevented by the dithiol DTT but not by
the endogenous monothiol glutathione, which
sugggests that two cysteine residues in close
proximity might be involved in the mechanism
of inhibition. This is in contrast to the inhibi-
tion of 11β-HSD2 by dithiocarbamates, which
irreversibly inhibit the enzyme, probably
through covalent modification of a cysteine
residue by attachment of a carbamoyl group
(Atanasov et al. 2003).
The inhibition of 11β-HSD2 by dithio-
carbamates (Atanasov et al. 2003) and organ-
otins seems to involve distinct cysteine residues,
as addition of high concentrations of cofactor
NAD+ partially protected from dithiocarba-
mates but not from organotins. Site-directed
mutagenesis and functional analysis revealed an
essential role of Cys128, Cys188, Cys228, and
Cys264 for enzyme stability and/or catalytic
activity in addition to the previously described
Cys90. To begin to understand the basis for the
different activities of these mutant enzymes, we
applied a 3-D structural model of 11β-HSD2
(Arnold et al. 2003; Atanasov et al. 2003) to
investigate the structure surrounding each of
these cysteines (Figure 7). Cys48 and Cys371
are located in hydrophobic segments thought
to associate with cellular membranes in the
endoplasmic reticulum. These residues are
outside the 260 residue core segment com-
prising the catalytically active domain in
homologs of 11β-HSD2 and were not ana-
lyzed further. The 3-D model shows that
Cys127, Cys128, and Cys248 do not interact
with sites on 11β-HSD2 critical for binding of
either NAD+, substrate, or the catalytically
active Tyr232. Figure 7A shows that these cys-
teines have few stabilizing interactions with
Table 2. Analysis of the kinetic parameters of wild-type 11β-HSD2 and cysteine to serine mutants.a
Km Vmax TBT
(nM) (nmol × h–1 × mg–1) [IC50 ± SD (µM)]
Wild-type 62 ± 17 2.14 ± 0.32 1.90 ± 0.46
Cys48Ser 71 ± 23 1.93 ± 0.17 2.11 ± 0.33
Cys90Ser ND ND ND
Cys127Ser 67 ± 19 2.48 ± 0.36 2.23 ± 0.33
Cys128Ser 97 ± 21 3.02 ± 0.28 1.87 ± 0.53
Cys188Ser 49 ± 16 2.78 ± 0.37 1.95 ± 0.38
Cys228Ser ND ND ND
Cys248Ser 51 ± 13 2.49 ± 0.43 2.07 ± 0.47
Cys264Ser 173 ± 32 3.29 ± 0.35 4.20 ± 0.44
Cys371Ser 74 ± 20 2.08 ± 0.28 2.17 ± 0.50
ND, not determined. 
aData are mean ± SD from at least three independent experiments measured in triplicate.
Figure 3. Effect of preincubation on 11β-HSD2 activ-
ity. The oxidation of cortisol to cortisone was deter-
mined after preincubation for 5 or 10 min with vehicle
(control), 1.5 µM TPT, or 2 µM TBT in lysates of HEK-
293 cells expressing 11β-HSD2. Data are mean ± SD
from at least three independent experiments.
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Figure 4. Effects of dilution of the enzyme-inhibitor
(EI) complex on TBT-dependent inhibition of
11β-HSD2. Lysates from HEK-293 cells expressing
11β-HSD2 were split into two equal aliquots. TBT
was added to the ﬁrst aliquot, and the same volume
of vehicle, serving as a control, was added to the
second. Both aliquots were incubated for 5 min at
37°C, followed by determination of the activity of
the control and EI mixture either undiluted or after a
2- or 4-fold dilution. Data are mean ± SD from at
least three independent experiments measured in
triplicate.
*p < 0.05.
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*other amino acids and are oriented to the
solvent, away from the catalytic pocket.
As described previously (Atanasov et al.
2003), the thiol group of Cys90 has several
interactions with amino acids that stabilize
Glu115 and Asp91 (Figure 7B). Glu115 has crit-
ical hydrogen bonds with the ribose hydroxyl
on NAD+ that are important in stabilizing
binding of the cofactor and in maintaining its
orientation to the substrate. Thus, the loss of
the stabilizing effects of Cys90 on the orienta-
tion of Glu115 leads to an inactive 11β-HSD2.
Similarly, the thiol group on Cys188 stabi-
lizes several amino acids that interact with the
pyrophosphate segment of NAD+ (Figure 7C).
However, like Cys90, Cys188 is not directly
involved in interactions with the cofactor, and
it appears that if the thiol group is replaced
with a serine hydroxyl group, there remains
sufﬁcient stabilization of the structure near the
pyrophosphate group in mutant Cys188Ser to
retain some catalytic activity.
Cys228 is in the loop that precedes the cata-
lytically active Tyr232 (Figure 7D). Evidence
from solved 3-D structures of 11β-HSD2
homologs, such as 17β-HSD1, clearly shows
that this loop stabilizes the position of the
nicotinamide ring and the catalytic Tyr232 with
the steroid substrate to promote catalysis
(Breton et al. 1996; Ghosh et al. 1994; Tanaka
et al. 1996; Yamashita et al. 1999). The thiol
on Cys228 stabilizes the backbone oxygen in
Pro227, which is an important structural amino
acid that is also in the loop that positions the
catalytic tyrosine, the nicotinamide ring, and
the steroid. Cys228 also stabilizes Glu277, which
belongs to a helix in the substrate binding site.
Thus, the thiol group on Cys228 interacts with
amino acids on 11β-HSD2 that are important
in substrate binding, which explains the loss of
activity of mutant Cys228Ser.
Figure 7D also shows that the thiol group
of Cys264 has important interactions with
Leu284, Ala285, and Pro288, which are part of
the helix in the C-terminal region of
11β-HSD2 that likely is important in the sub-
strate binding site, based on analyses of
17β-HSD2 and other homologs (Tanaka et al.
1996) of 11β-HSD2. Our experimental data
indicate that the serine hydroxyl group can
partially take over the function of the thiol on
Cys264. Together, these ﬁndings suggest that
Cys228 and Cys264 may be involved in the
interactions with organotins, and interference
with the function of their thiol groups may be
responsible for inactivation of 11β-HSD2 by
organotins.
Although the chemical nature of organ-
otin–protein interactions is not completely
understood at present, it is believed that most
of the properties of organotins are a result of the
nature of C–Sn bonds that can be attacked by
both nucleophilic and electrophilic reagents
(Hoch 2001). Buck et al. recently described the
interaction of organotins with the membrane
protein stannin (Buck et al. 2003, 2004). A
nonapeptide derived from stannin containing
the sequence Cys–Trp–Cys was able to dealky-
late TMT, followed by binding of the resulting
DMT. Buck et al. (2003, 2004) further showed
that DTT bound TMT without inducing
dealkylation. Stannin efficiently dealkylated
organotins with short alkyl side chains with,
weak binding observed for TBT and TOT.
11β-HSD2 does not possess a Cys–Xaa–
Cys motif, and Cys127 and Cys128 are unlikely
to be the target residues for inhibition by organ-
otins, as replacement of either of these residues
did not affect the organotin-dependent inhibi-
tion of the mutant enzymes. Replacing Cys228
by serine completely abolished enzyme activ-
ity, indicating an important functional role of
this residue. Mutating Cys264 to serine led to a
well-expressed enzyme with only slightly
reduced catalytic efﬁciency. This mutant was
less sensitive to organotin-dependent inhibition.
The potency of organotins in inhibiting
11β-HSD2 is equal to or greater than that
reported for other enzymes involved in steroid
hormone metabolism, including cytochrome
P450 aromatase (Lo et al. 2003), 5α-reductases
(Doering et al. 2002), and rat testis microsomal
3β-HSD (McVey and Cooke 2003). As men-
tioned earlier, organotins represent ubiquitous
contaminants of the water ecosystem. Although
most often present at lower nanomolar concen-
trations, organotins accumulate in aquatic
organisms, with up to 70,000 times higher
organotin concentrations in plankton and other
organisms than in sea water (Takahashi et al.
1999). As little as 200 g of contaminated shell-
ﬁsh could be sufﬁcient to reach the toxic daily
intake of TBT (0.25 µg/kg body weight)
(McVey and Cooke 2003). Another major
source of organotins for humans is the drinking
water in locations where PVC water pipes are
used. A study of organotin levels in Canadian
drinking water distributed through PVC pipes
in 1996 revealed total concentrations of differ-
ent organotins < 50 ng Sn/L, although in some
occasions values > 250 ng Sn/L were detected
(Sadiki and Williams 1999). Although the IC50
values of organotins for 11β-HSD2 in the pre-
sent study were in the high nanomolar and low
micromolar range, the accumulation of organ-
otins in specific organs and tissues including
brain, liver, and kidneys may lead to high local
concentrations, as has been found in aquatic
organisms. In addition Chicano et al. (2001)
provided evidence that organotins are located in
the upper part of the phospholipid palisade
near the lipid–water interface and affect the
degree of hydration of the phospholipid car-
bonyl moiety. Thus, intracellular organotin
concentrations might be highest at the surface
of membranes, and 11β-HSD2 might be
exposed to concentrations much higher than
those in the solution.
The increased glucocorticoid-mediated
effects due to the inhibition of 11β-HSD2 are
expected to disturb several essential physiologic
processes. The effect of TBT and its major
metabolite DBT to suppress T-cell–dependent
immune functions by causing thymus atrophy
has been extensively studied (Krajnc et al. 1984;
Seinen et al. 1977a, 1977b; Snoeij et al. 1988;
Tryphonas et al. 2004; Vos et al. 1984a, 1990).
A single dose of TBT, DBT, or DOT induced
dose-dependent reductions in the weight of the
thymus, spleen, and lymph node (Seinen et al.
1977b). The effect of TBT was less pronounced
and slightly delayed compared with DBT, indi-
cating that in vivo TBT is metabolized to the
more toxic DBT (Snoeij et al. 1988). The thy-
motoxic effects of organotins are completely
reversible (Seinen et al. 1977b). A selective
inhibition of the proliferation of immature
Atanasov et al.
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Figure 5. Additive inhibitory effect of a mixture of
organotins on 11β-HSD2 activity. Conversion of cor-
tisol to cortisone by 11β-HSD2 stably expressed in
intact HEK-293 cells was measured in a volume of
50 µL cell culture medium containing 40 nM cortisol
and the corresponding amount of the organotin, as
indicated (see “Materials and Methods”). Data
were normalized to the control and are mean ± SD
from at least three independent experiments meas-
ured in triplicate.
*Statistical significance of p < 0.01 compared with all
other values.
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Figure 6. Dose–response curves for TBT-induced
inhibition of 11β-HSD2 in intact cells expressing
endogenous 11β-HSD2. RCCD-2, rat renal cortical
collecting duct cell line; JEG-3, human choriocarci-
noma cell line; SW-620, human colon adenocarci-
noma cell line. Details on culture conditions and
activity assay in intact cells are given in “Materials
and Methods.”
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SW-620CD4–/CD8+ thymocytes by organotins seems
to be responsible for the observed depletion of
CD4+/CD8+ thymocytes, which show a rapid
turnover.
11β-HSD enzymes play a pivotal role in
regulating proliferation and differentiation in
various tissues. 11β-HSD1 generates active
glucocorticoids and promotes differentiation,
and 11β-HSD2 inactivates glucocorticoids,
thereby promoting proliferation. 11β-HSD1
and 11β-HSD2 were both expressed in whole
mouse thymus (Moore et al. 2000; Speirs et al.
2004), although the exact subtype-specific
expression pattern of 11β-HSD enzymes
remains to be determined. In the acute stress
response, the high level of glucocorticoids
induces thymus involution (Schuurman et al.
1992). Organotin-dependent inhibition of
11β-HSD2 may cause antiproliferative effects
on immature thymocytes by increasing locally
the ratio of active to inactive glucocorticoids or,
alternatively, by increasing systemic glucocorti-
coid levels. Both organotin-induced inhibition
of 11β-HSD2 and thymotoxicity are reversible.
Experiments in mice showed maximal thy-
mocyte apoptosis 8 hr after glucocorticoid
administration, followed by full recovery after
18 hr (Ishii et al. 1997). There was a signiﬁcant
depletion of CD4+/CD8+ thymocytes. A
delayed, dose-dependent apoptosis of thymo-
cytes, reaching maximal effect after 24 hr, was
observed when mice were treated with a single
dose of the 11β-HSD inhibitor GA (Horigome
et al. 1999). Thymocyte apoptosis was induced
dose-dependently by corticosterone in vitro.
GA alone did not induce apoptosis in vitro,
suggesting that elevated corticosterone levels
due to inhibition of 11β-HSD2 may cause the
apoptosis. Similarly, organotin-dependent inhi-
bition of 11β-HSD2 and subsequent locally
enhanced glucocorticoid levels may contribute
to the immunotoxicity of these compounds.
However, thymus atrophy was also observed in
DBT- and TBT-treated adrenalectomized rats
(Seinen and Willems 1976; Snoeij et al. 1985),
and no extensive cell destruction was observed
in DBT- and TBT-treated rats compared with
rats treated with very high glucocorticoid
concentrations (La Pushin and de Harven
1971). These findings suggest that the
immunotoxic effects of organotins are caused
by a glucocorticoid-dependent and a glucocor-
ticoid-independent mechanism.
The glucocorticoid-dependent effects
caused by organotins may be most critical dur-
ing pregnancy, where fetal development is
highly sensitive to glucocorticoids (Seckl et al.
2000). The lower birth weight and decreased
weight gain in the offspring after exposure of
organotins during pregnancy is a phenotype
also observed as a result of exposure to exces-
sive levels of glucocorticoids. Enhanced glu-
cocorticoid action due to inhibition of
11β-HSD2, which in the placenta protects the
fetus from high maternal levels, or due to treat-
ment with synthetic glucocorticoids that can-
not be inactivated by 11β-HSD2, such as
dexamethasone (Rebuffat et al. 2004), have
been associated with reduced birth weight and
irreversible changes in the cardiovascular system
with complications in later life (Seckl et al.
2000). Thus, inhibition of 11β-HSD2 may be
Inhibition of 11β-HSD2 by organotins
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Figure 7. Predicted interactions of cysteine residues in the conserved core domain of 11β-HSD2. (A) Cys127, Cys128, and Cys248 are oriented into the solvent, away from
the catalytic pocket, and have few stabilizing interactions with other residues. (B) Cys90 interacts with amino acids that stabilize Glu115 and Asp91, which have a critical
role by forming hydrogen bonds to the ribose hydroxyl on NAD+ that are important to stabilize binding of the cofactor and maintain its orientation to the substrate.
(C) Cys188 is not directly involved in interactions with NAD+ but stabilizes several amino acids that interact with the pyrophosphate segment of the cofactor. (D) The thiol
on Cys228 stabilizes the position of Pro227 and Glu277, which are important for positioning of the catalytic tyrosine and the nicotinamide ring and for binding of the steroid
substrate. The thiol group of Cys264 has important interactions with Leu284, Ala285, and Pro288 in the helix in the C-terminal region of 11β-HSD2, which is important for sub-
strate binding. Predicted interatomic distances in angstroms are depicted by number. Blue: nitrogen; green: carbon; purple: phosphorus; red: oxygen; and yellow: sulfur.
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one reason that offspring from pregnant rats
treated with organotins show significantly
reduced birth weight (Adeeko et al. 2003;
Cooke et al. 2004; Crofton et al. 1989).
Conclusions
This work demonstrates the disruption of the
11β-HSD2–dependent inactivation of gluco-
corticoids by organotins. Various organotin
compounds inhibit 11β-HSD2, mainly by a
reversible mode of inhibition, and show addi-
tive effects. Endogenous glutathione cannot
prevent the organotin-induced inhibition of
11β-HSD2, which explains the comparable
inhibitory kinetics obtained in experiments
with cell lysates and in intact cells. The results
suggest that enhanced glucocorticoid concen-
trations due to disruption of 11β-HSD2
function may contribute to the observed organ-
otin-dependent toxicity in glucocorticoid sensi-
tive tissues such as thymus and placenta.
Clearly, additional experiments in vivo must be
performed to elucidate the relevance of organ-
otin-dependent interference with glucocorticoid
action and its pathophysiologic consequences.
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